All stock reports

ABLBL evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • Financial data quality flags require resolution.
  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-08-25T23:17:22.689816+00:00

Metrics

latest_annual_period
2026-03-31
revenue
83958100000.0
net_income
1710500000.0
operating_cash_flow
10978600000.0
free_cash_flow
7720600000.0
total_assets
87200500000.0
total_liabilities
73078700000.0
total_equity
14121800000.0
cash
1078500000.0
total_debt
30181000000.0
revenue_growth
0.0734463060132764
earnings_growth
1.8699664429530203
net_margin
0.020373257613023638
roe
0.12112478579217947
debt_to_equity
2.137192142644705
cash_conversion
6.418357205495469
free_cash_flow_margin
0.0919577741754518
trailing_pe
65.0355
forward_pe
0.0
peg_ratio
Not supplied
price_to_book
8.073
dividend_yield
0.0

Other positional research

Research only

1 opportunity assessments; compare evidence and conditions below.

Price Dislocation

Research only. Direction: LONG.

Flags large price dislocations for research without asserting unsupported fundamental quality

  • No active, unexpired validation authority for this exact strategy and horizon.
  • A source-backed entry, invalidation, exit and cost plan is not supplied.
Eligible expression
None selected
Expression comparison
No eligible instrument selected.
Invalidation
Continued price deterioration or adverse fundamental evidence
Entry rule
Not supplied
Entry range (INR)
Not supplied
Exit / review rule
Not supplied
Planned exit
Not supplied
Plan valid until
Not supplied
Promotion reference
Not supplied
Instrument scenarios in INR; quantities are illustrative, not personal sizing
InstrumentEvidence statusContractQuantityCapital / marginTarget P&L after costsStop-level scenario P&LStress lossConditions and limitations
NO_POSITIONAvailableNot suppliedNot suppliedNot supplied0.000.00Not suppliedNo new position; incremental trading P&L is zero.
CASHUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
FUTURESUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
OPTIONSUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
  • No reader capital or loss budget supplied
Decision provenance and limitations
Decision ID
decision-dd5a178662a6693969bfa180b35d2eb0daf41a4df6c2baf8bce83a9c751a7684
Policy
stock-decisions-v1
Evidence bundle hash
51be6641e1b93284589353156f6c50ecd17e1de66b11aa017ef440e91c25f9f6
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: b9d06d67087c44cee1af50d6434e3074979f6a3310c3bb2fc072e575916f8b0f
  • daily-price: c0cbd61443ee609ad3a6c9e83aa8c7701f4074bc29fa701c264f7a5521d90929
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Evidence briefing

The local language model selected and grouped the following supplied facts.

Overview

Price source verification: REPAIRED. The trailing 5-session price return was -5.28%. The trailing 20-session price return was -10.07%. The trailing 60-session price return was -19.99%. The trailing 250-session price return was -44.81%. Average cached traded value over twenty sessions was INR 185,760,043.

Risks

The closing price was -49.40% below its highest close in the available trailing year. The cached financial metric debt to equity is 2.137192142644705. Financial data check: high_leverage: debt/equity above 2. The cached financial metric net margin is 0.020373257613023638. The cached financial metric revenue growth is 0.0734463060132764.

Follow Up

The cached financial metric latest annual period is 2026-03-31. Fundamental coverage is FULL_STATEMENTS; retrieved 2026-08-25T23:17:22.689816+00:00 from EODHD.

Cached observations and evidence limits